Interactions of GYKI 52466 and NBQX with cyclothiazide at AMPA receptors: Experiments with outside-out patches and EPSCs in hippocampal neurones

Neuropharmacology

Volumn 37, Issue 10-11, 1998, Pages 1299-1320

  Rammes, Gerhard ^a   Swandulla, Dieter ^a   Spielmanns, Peter ^b   Parsons, Chris G ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Department of Pharmacology Merz ^*  (Germany)

Author keywords

Allosteric interactions; AMPA receptor mediated EPSCs; Cyclothiazide; Glutamate induced currents; GYKI 52466; Hippocampal culture; Kinetics; NBQX; Outside out patch clamp; Slice

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; CYCLOTHIAZIDE; GLUTAMIC ACID;

ALLOSTERISM; ANIMAL TISSUE; BRAIN SLICE; CONFERENCE PAPER; CONTROLLED STUDY; DESENSITIZATION; DRUG RECEPTOR BINDING; EMBRYO; HIPPOCAMPUS; MALE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT;

EID: 0032192551     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00111-7     Document Type: Conference Paper

References (92)

1. Arai, A., Silberg, J., Kessler, M., Lynch, G., 1995. Effect of thiocyanate on AMPA receptor mediated responses in excized patches and hippocampal slices. Neuroscience 66, 815-827.
2. Arai, A., Kessler, M., Ambros-Ingerson, J., et al., 1996. Effects of a centrally active benzoylpyrrolidine drug on AMPA receptor kinetics. Neuroscience 75, 573-585.
3. Arvin, B., Moncada, C., Lepeillet, E., Chapman, A., Meldrum, B.S., 1992. GYKI-52466 blocks the increase in extracellular glutamate induced by ischaemia. Neuroreport 3, 235-238.
4. Arvin, B., Lekieffre, D., Graham, J.L., Moncada, C., Chapman, A.G., Meldrum, B.S., 1994. Effect of the non-NMDA receptor antagonist GYKI-52466 on the microdialysate and tissue concentrations of amino acids following transient forebrain ischaemia. J. Neurochem. 62, 1458-1467.
5. Audinat, E., Lambolez, B., Rossier, J., et al., 1996. Functional and molecular analysis of glutamate-gated channels by patch-clamp and RT-PCR at the single cell level. Neurochem. Int. 28, 119-136.
6. Barnes, J.M., Dev, K.K., Henley, J.M., 1994. Cyclothiazide unmasks AMPA-evoked stimulation of [3H]-1-glutamate release from rat hippocampal synaptosomes. Br. J. Pharmacol. 113, 339-341.
7. Benveniste, M., Mienville, J.M., Sernagor, E., Mayer, M.L., 1990. Concentration-jump experiments with NMDA antagonists in mouse cultured hippocampal neurons. J. Neurophysiol. 63, 1373-1384.
8. Bertolino, M., Baraldi, M., Parenti, C., et al., 1993. Modulation of AMPA/kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus. Recept. Channel 1, 267-278.
9. Bijak, M., Jarolimek, W., Misgeld, U., 1991. Effects of antagonists on quisqualate and nicotinic receptor-mediated currents of midbrain neurones in culture. Br. J. Pharmacol. 102, 699-705.
10. Blanton, M.G., Lo-Turco, J.J., Kriegstein, A.R., 1989. Whole cell recording from neurones in slices of reptilian and mammalian cerebral cortex. J. Neurosci. Meth. 30, 203-210.
11. Bleakman, D., Ballyk, B.A., Schoepp, D.D., et al., 1996. Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles. Neuropharmacology 35, 1689-1702.
12. Bliss, T.V.P., Collingridge, G.L., 1993. A synaptic model of memory - long-term potentiation in the hippocampus. Nature 361, 31-39.
13. Boxall, A.R., Garthwaite, J., 1995. Synaptic excitation mediated by AMPA receptors in rat cerebellar slices is selectively enhanced by aniracetam and cyclothiazide. Neurochem. Res. 20, 605-609.
14. Clements, J.D., Lester, R.A.J., Tong, G., Jahr, C.E., Westbrook, G.L., 1992. The time course of glutamate in the synaptic cleft. Science 258, 1498-1501.
15. Collingridge, G.L., Lester, R.A., 1989. Excitatory amino acids receptors in the vertebrate central nervous system. Pharmacol. Rev. 41, 143-210.
16. Colquhoun, D., Jonas, P., Sakmann, B., 1992. Action of brief pulses of glutamate on AMPA/kainate receptors in patches from different neurones of rat hippocampal slices. J. Physiol. 458, 261-287.
17. Danysz, W., Parsons, C.G., Bresink, I., Quack, G., 1995a. Glutamate in CNS disorders: a revived target for drug development? Drug News Perspect. 8, 261-277.
18. Danysz, W., Zajaczkowski, W., Parsons, C.G., 1995b. Modulation of learning processes by ionotropic glutamate receptor ligands. Behav. Pharmacol. 6, 455-474.
19. Desai, M.A., Burnett, J.P., Ornstein, P.L., Schoepp, D.D., 1995. Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists. J. Pharmacol. Exp. Ther. 272, 38-43.
20. Diamond, J.S., Jahr, C.E., 1995. Asynchronous release of synaptic vesicles determines the time course of the AMPA receptor-mediated EPSC. Neuron 15, 1097-1107.
21. Donevan, S.D., Rogawski, M.A., 1993. GYKI 52466, a 2,3-benzodiazepine, is a highly selective noncompetitive antagonist of AMPA/kainate receptor responses. Neuron 10, 51-59.
22. Donevan, S.D., Yamaguchi, S., Rogawski, M.A., 1994. Non-N-D-aspartate receptor antagonism by 3-N-substituted 2,3 benzodiazepines: relationship to anticonvulsant activity. J. Pharmacol. Exp. Ther. 271, 25-29.
23. Fleck, M.W., Bahring, R., Patneau, O.K., Mayer, M.L., 1996. AMPA receptor heterogeneity in rat hippocampal neurons revealed by differential sensitivity to cyclothiazide. J. Neurophysiol. 75, 2322-2333.
24. Gaspary, H.L., Simon, R.P., Graham, S.H., 1994. BW1003c87 and NBQX but not CGS19755 reduce glutamate release and cerebral ischemic necrosis. Eur. J. Pharmacol. 262, 197-203.
25. 2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron 15, 193-204.
26. Geoffroy, M., Lambolez, B., Audinat, E., Hamon, B., Crepel, F., Rossier, J., Kado, R.T., 1991. Reduction of desensitization of a glutamate ionotropic receptor by antagonists. Mol. Pharmacol. 39, 587-591.
27. Goldstein, J.M., Litwin, L.C., 1993. NBQX is a selective non-NMDA receptor antagonist in rat hippocampal slice. Mol. Chem. Neuropathol. 18, 145-152.
28. 3H]AMPA binding to rat brain membranes - evidence that AMPA receptor desensitization increases agonist affinity. Brain Res. 628, 345-348.
29. Hestrin, S., 1992. Activation and desensitization of glutamate-activated channels mediating fast excitatory synaptic currents in the visual cortex. Neuron 9, 991-999.
30. Hollmann, M., Heinemann, S., 1994. Cloned glutamate receptors. Annu. Rev. Neurosci. 17, 31-108.
31. 2+ in cultured neurons from rat brain. J. Neurochem. 64, 2049-2056.
32. Isaacson, J.S., Nicoll, R.A., 1991. Aniracetam reduces glutamate receptor desensitization and slows the decay of fast excitatory synaptic currents in the hippocampus. Proc. Natl. Acad. Sci. 88, 10936EP.
33. Isaacson, J.S., Walmsley, B., 1996. Amplitude and time course of spontaneous and evoked excitatory postsynaptic currents in bushy cells of the anteroventral cochlear nucleus. J. Neurophysiol. 76, 1566-1571.
34. Ishida, A.T., Neyton, J., 1985. Quisqualate and L-glutamate inhibit retinal horizontal-cell responses to kaiante. Proc. Natl. Acad. Sci. 82, 1837-1841.
35. Javitt, D.C., Frusciante, M.J., Zukin, S.R., 1990. Rat brain N-methyl-D-aspartate receptors require multiple molecules of agonist for activation. Mol. Pharmacol. 37, 603-607.
36. Johansen, T.H., Chaudhary, A., Verdoorn, T.A., 1995. Interactions among GYKI-52466, cyclothiazide and aniracetam at recombinant AMPA and kainate receptors. Mol. Pharmacol. 48, 946-955.
37. Jonas, P., Spruston, N., 1994. Mechanisms shaping glutamate-mediated excitatory postsynaptic currents in the CNS. Curr. Opin. Neurobiol. 4, 366-372.
38. Jones, K.A., Wilding, T.J., Huettner, J.E., Costa, A.M., 1997. Desensitization of kainate receptors by kainate glutamate and diastereomers of 4-methylglutamate. Neuropharmacology 36, 853-863.
39. Kessler, M., Arai, A., Quan, A., Lynch, G., 1996. Effect of cyclothiazide on binding properties of AMPA-type glutamate receptors: lack of competition between cyclothiazide and GYKI 52466. Mol. Pharmacol. 49, 123-131.
40. 2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons. Biochem. Pharmacol. 50, 1761-1774.
41. Livsey, C.T., Costa, E., Vicini, S., 1993. Glutamate-activated currents in outside-out patches from spiny versus aspiny hilar neurons of rat hippocampal slices. J. Neurosci. 13, 5324-5333.
42. Martin, R.L., Lloyd, H.G.E., Cowan, A.I., 1994. The early events of oxygen and glucose deprivation: setting the scene for neuronal death? Trends Neurosci. 17, 251-257.
43. Mayer, M.L., Vyklicky, L.J., Sernagor, E., 1989. A physiologists view of the N-methyl-d-aspartate receptor: an allosteric ion channel with multiple regulatory sites. Drug Develop. Res. 17, 263-280.
44. McEntee, W.J., Crook, T.H., 1993. Glutamate: its role in learning, memory and aging brain. Psychopharmacology 11, 391-401.
45. Misgeld, U., Müller, W., Polder, H.R., 1989. Potentiation and supression by eserine of muscarinic synaptic synaptic transmission in the guinea-pig hippocampal slice. J. Physiol. 409, 191-206.
46. Mosbacher, J., Schoepfer, R., Monyer, H., Burnashev, N., Seeburg, P.H., Ruppersberg, J.P., 1994. A molecular determinant for submillisecond desensitization in glutamate receptors. Science 266, 1059-1062.
47. Nowak, L., Bregestovski, P., Ascher, P., Herbert, A., Prochiantz, A., 1984. Magnesium gates glutamate-activated channels in mouse central neurons. Nature 307, 462-465.
48. Okada, M., Kohara, A., Yamaguchi, T., 1996. Characterization of YM90K, a selective and potent antagonist of AMPA receptors in rat cortical mRNA-injected Xenopus oocytes. Eur. J. Pharmacol. 309, 299-306.
49. Otis, T.S., Wu, Y.C., Trussell, L.O., 1996. Delayed clearance of transmitter and the role of glutamate transporters at synapses with multiple release sites. J. Neurosci. 16, 1634-1644.
50. Ozawa, S., Rossier, J., 1996. Molecular basis for functional differences of AMPA-subtype glutamate receptors. News in Physiol. Sci. 11, 77-82.
51. Palmer, A.J., Lodge, D., 1993. Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodi azepine GYKI-53655. Eur. J. Pharmacol. Molec. Pharmacol. 244, 193-194.
52. Parsons, C.G., Gruner, R., Rozental, J., 1994. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5h-2,3-benzodiazepine (GYKI 52466). Neuropharmacology 33, 589-604.
53. Partin, K.M., Patneau, D.K., Winters, C.A., Mayer, M.L., Buonanno, A., 1993. Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavalin-A. Neuron 11, 1069-1082.
54. Partin, K.M., Fleck, M.W., Mayer, M.L., 1996. AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam and thiocyanate. J. Neurosci. 16, 6634-6647.
55. Partin, K.M., Mayer, M.L., 1996. Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI 53655. Mol. Pharmacol. 49, 142-148.
56. Patneau, D.K., Vyklicky, L., Mayer, M.L., 1993. Hippocampal neurons exhibit cyclothiazide-sensitive rapidly desensitizing responses to kainate. J. Neurosci. 13, 3496-3509.
57. Patneau, D.K., Mayer, M.L., 1990. Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors. J. Neurosci. 10, 2385-2399.
58. Patneau, D.K., Mayer, M.L., 1991. Kinetic analysis of interactions between kainate and AMPA: evidence for activation of a single receptor in mouse hippocampal neurons. Neuron 6, 785-795.
59. Pelletier, M.R., Hablitz, J.J., 1994. Altered desensitization produces enhancement of EPSPs in neocortical neurons. J. Neurophysiol. 72, 1032-1036.
60. Perouansky, M., Grantyn, R., 1989. Separation of quisqualate-and kainate-selective glutamate receptors in cultured neurons from the rat superior colliculus. J. Neurosci. 9, 70-80.
61. Petitet, F., Blanchard, J.C., Doble, A., 1995. Effects of AMPA receptor modulators on the production of arachidonic acid from striatal neurons. Eur. J. Pharmacol. Molec. Pharmacol. 291, 143-151.
62. Phillis, J.W., Smithbarbour, M., Perkins, L.M., Oregan, M.H., 1993. GYKI-52466 and ischemia-evoked neruotransmitter amino acid release from rat cerebral cortex. Neuroreport 4, 109-111.
63. Raman, M., Trussell, O., 1992. The Kinetics of the Response to Glutamate and Kainate in Neurons of the Avian Cochlear Nucleus. Neuron 9, 173-186.
64. Raman, I.M., Trussell, L.O., 1995. The mechanism of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor desensitization after removal of glutamate. Biophys. J. 68, 137-146.
65. Raman, I.M., Zhang, S., Trussell, L.O., 1994. Pathway-specific variants of AMPA receptors and their contribution to neuronal signaling. J. Neurosci. 14, 4998-5010.
66. Rammes, G., Parsons, C.G., Muller, W., Swandulla, D., 1994. Modulation of fast excitatory synaptic transmission by cyclothiazide and GYKI 52466 in the rat hippocampus. Neurosci. Lett. 175, 21-24.
67. Rammes, G., Swandulla, D., Collingridge, G.L., Hartmann, S., Parsons, C.G., 1996. Interactions of 2,3-benzodiazepines and cyclothiazide at AMPA receptors: patch clamp recordings in cultured neurones and area CA1 in hippocampal slices. Br. J. Pharmacol. 117, 1209-1221.
68. Randle, J.C.R., Guet, T., Cordi, A., Lepagnol, J.M., 1992. Competitive inhibition by NBQX of kainate/AMPA receptor currents and excitatory synaptic potentials - importance of 6-nitro substitution. Eur. J. Pharmacol. 215, 237-244.
69. Rao, T.S., der, J.A., Mick, S.J., Emmett, M.R., Iyengar, S., Wood, P.L., 1990. 6,7-Dinitroquinoxaline-2,3-dione and 6-nitro,7-cyanoquinoxaline-2,3-dione antagonize responses mediated by N-methyl-d-aspartate and NMDA-associated glycine recognition sites in vivo: measurements of cerebellar cyclic-GMP. Neuropharmacology 29, 1031-1035.
70. Renard, A., Crepel, F., Audinat, E., 1995. Evidence for two types of non-NMDA receptors in rat cerebellar purkinje cells maintained in slice cultures. Neuropharmacology 34, 335-346.
71. Rock, D.M., Campbell, G.W., 1993. Cyclothiazide and GYKI-52466 affect AMPA-induced neuronal damage of cultured cortical neurons by actions at distinct sites. Soc. Neurosci. Abs. 19, 294.
72. Rogawski, M.A., 1993. Therapeutic potential of excitatory amino acid antagonists-channel blockers and 2,3-benzodiazepines. Trends Pharmacol. Sci. 14, 325-331.
73. Rossi, D.J., Alford, S., Mugnaini, E., Slater, N.T., 1995. Properties of transmission at a giant synapse in cerebellum: the mossy fiberunipolar brush cell synapse. J. Neurophysiol. 74, 24-42.
74. Sather, W., Dieudonne, S., Macdonald, J.F., Ascher, P., 1992. Activation and desensitization of N-methyl-d-aspartate receptors in nucleated outside-out patches from mouse neurones. J. Physiol. 450, 643-672.
75. Schürmann, B., Wu, X.Q., Dietzel, I.D., Lessmann, V., 1997. Differential modulation of AMPA receptor mediated currents by evans blue in postnatal rat hippocampal neurones. Br. J. Pharmacol. 121, 237-247.
76. Seeburg, P.H., 1993. The molecular biology of mammalian glutamate receptor channels. Trends Pharmacol. Sci. 14, 297-303.
77. Sheardown, M.J., Meisen, E.O., Hansen, A.J., Jacobsen, P., Honore, T., 1990. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science 247, 571-574.
78. Silver, R.A., Colquhoun, D., Cull Candy, S.G., Edmonds, B., 1996. Deactivation and desensitization of non-NMDA receptors in patches and the time course of EPSCs in rat cerebellar granule cells. J. Physiol. 493, 167-173.
79. Swandulla, D., Misgeld, U., 1990. Development and properties of synaptic mechanisms in network of rat hypothalamic neurons grown in culture. J. Neurophysiol. 64, 715-726.
80. Tang, C.M., Dichter, M., Morad, M., 1989. Quisqualate activates a rapidly inactivating high conductance ionic channel in hippocampal neurons. Science 243, 1474-1477.
81. Thio, L.L., Clifford, D.B., Zorumski, C.F., 1991. Characterization of quisqualate receptor desensitization in cultured postnatal rat hippocampal neurons. J. Neurosci. 11, 3430-3441.
82. Trussell, L.D., Fischbach, G.D., 1989. Glutamate receptor desensitization and its role in synaptic transmission. Neuron 3, 209-218.
83. Trussell, L.O., Zhang, S., Raman, I.M., 1993. Desensitization of AMPA receptors upon multiquantal neurotransmitter release. Neuron 10, 1185-1196.
84. Wilding, T.J., Huettner, J.E., 1995. Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines. Mol. Pharmacol. 47, 582-587.
85. Wilding, T.J., Huettner, J.E., 1997. Activation and desensitization of hippocampal kainate receptors. J. Neurosci. 17, 2713-2721.
86. Yamada, K.A., Tang, C.M., 1993. Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents. J. Neurosci. 13, 3904-3915.
87. Yamada, K.A., Turetsky, S.M., 1996. Allosteric interactions between cyclothiazide and AMPA/kainate receptor antagonists. Br. J. Pharmacol. 117, 1663-1672.
88. Zhang, S., Trussell, L.O., 1994. Voltage clamp analysis of excitatory synaptic transmission in the avian nucleus magnocellularis. J. Physiol. 480, 123-136.
89. Zhou, F.M., Hablitz, J.J., 1997. Rapid kinetics and inward rectification of miniature EPSCs in layer I neurons of rat neocortex. J. Neurophysiol. 77, 2416-2426.
90. Zhou, N., Hammerland, L.G., Parks, T.N., 1993. Gamma-D-glutamylaminomethyl sulfonic acid (GAMS) distinguishes kainic acid-induced from AMPA-induced responses in Xenopus oocytes expressing chick brain glutamate receptors. Neuropharmacology 32, 767-775.
91. Zorumski, C.F., Yamada, K.A., Price, M.T., Olney, J.W., 1993. A benzodiazepine recognition site associated with the non-NMDA glutamate receptor. Neuron 10, 61-67.
92. Zorumski, C.P., Mennerick, S., Que, J., 1996. Modulation of excitatory synaptic transmission by low concentrations of glutamate in cultured rat hippocampal neurons. J. Physiol. 494, 465-477.